The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration
Open accessAbstract
Encapsidation of host restriction factor APOBEC3G (A3G) into vif -deficient human immunodeficiency virus type 1 (HIV-1) blocks virus replication at least partly by C-to-U deamination of viral minus-strand DNA, resulting in G-to-A hypermutation. A3G may also inhibit HIV-1 replication by reducing viral DNA synthesis and inducing viral DNA degradation. To gain further insight into the mechanisms of viral inhibition, we examined the metabolism of A3G-exposed viral DNA. We observed that an overall 35-fold decrease in viral infectivity was accompanied by a five- to sevenfold reduction in viral DNA synthesis. Wild-type A3G induced an additional fivefold decrease in the amount of viral DNA that was integrated into the host cell genome and similarly reduced the efficiency with which HIV-1 preintegration complexes (PICs) integrated into a target DNA in vitro. The A3G C-terminal catalytic domain was required for both of these antiviral activities. Southern blotting analysis of PICs showed that A3G reduced the efficiency and specificity of primer tRNA processing and removal, resulting in viral DNA ends that are inefficient substrates for integration and plus-strand DNA transfer. However, the decrease in plus-strand DNA transfer did not account for all of the observed decrease in viral DNA synthesis associated with A3G. These novel observations suggest that HIV-1 cDNA produced in the presence of A3G exhibits defects in primer tRNA processing, plus-strand DNA transfer, and integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Self-citationInduction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 708
A quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S. T., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 687
Hypermutation of HIV-1 DNA in the Absence of the Vif Protein
Lecossier, D., Bouchonnet, F., Clavel, F., & Hance, A. J. (2003) · Science · doi:10.1126/science.1083338 · Cited by 651
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 597
Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase
Di Noia, J., & Neuberger, M. S. (2002) · Nature · doi:10.1038/nature00981 · Cited by 587
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., & Gabuzda, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313093200 · Cited by 474
The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G
Conticello, S. G., Harris, R. S., & Neuberger, M. S. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.034 · Cited by 469
Self-citationVif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
von Schwedler, U., Song, J., Aiken, C., & Trono, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4945-4955.1993 · Cited by 444
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Self-citationSelection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes
Vartanian, J. P., Meyerhans, A., Asjö, B., & Wain-Hobson, S. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1779-1788.1991 · Cited by 341
Beale, R. C. L., Petersen-Mahrt, S. K., Watt, I. N., Harris, R. S., Rada, C., & Neuberger, M. S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.01.046 · Cited by 339
Self-citationHolmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 308
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
Chelico, L., Pham, P., Calabrese, P., & Goodman, M. F. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1086 · Cited by 306
Complementary function of the two catalytic domains of APOBEC3G
Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., & Landau, N. R. (2005) · Virology · doi:10.1016/j.virol.2005.01.011 · Cited by 305
Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination
Bishop, K. N., Holmes, R. K., & Malim, M. H. (2006) · Journal of Virology · doi:10.1128/jvi.00839-06 · Cited by 293
Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T., & Wahl, S. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051512 · Cited by 293
Pathak, V. K., & Temin, H. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6019 · Cited by 280
Self-citationXu, H., Svarovskaia, E. S., Barr, R., Zhang, Y., Khan, M. A., Strebel, K., & Pathak, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400830101 · Cited by 238
Self-citationSchröfelbauer, B., Yu, Q., Zeitlin, S. G., & Landau, N. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.10978-10987.2005 · Cited by 218
Guo, F., Cen, S., Niu, M., Saadatmand, J., & Kleiman, L. (2006) · Journal of Virology · doi:10.1128/jvi.01038-06 · Cited by 196
Haché, G., Liddament, M. T., & Harris, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500382200 · Cited by 189
Self-citationSimon, J. H., & Malim, M. H. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5297-5305.1996 · Cited by 188
Buckman, J. S., Bosche, W. J., & Gorelick, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1469-1480.2003 · Cited by 186
Self-citationShindo, K., Takaori-Kondo, A., Kobayashi, M., Abudu, A., Fukunaga, K., & Uchiyama, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300376200 · Cited by 180
Kobayashi, M., Takaori‐Kondo, A., Miyauchi, Y., Iwaï, K., & Uchiyama, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500082200 · Cited by 170
Mansky, L. M., Preveral, S., Selig, L., Benarous, R., & Benichou, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7039-7047.2000 · Cited by 167
Self-citationChen, K., Huang, J., Zhang, C., Huang, S., Nunnari, G., Wang, F., Tong, X., Gao, L., Nikisher, K., & Zhang, H. (2006) · Journal of Virology · doi:10.1128/jvi.00206-06 · Cited by 161
Chen, R., Rouzic, E. L., Kearney, J. A., Mansky, L. M., & Bénichou, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403875200 · Cited by 157
Self-citationKaiser, S. M., & Emerman, M. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.875-882.2006 · Cited by 141
Julias, J. G., Ferris, A. L., Boyer, P. L., & Hughes, S. H. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6537-6546.2001 · Cited by 133
Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions
Xu, H., Chertova, E. N., Chen, J., Ott, D. E., Roser, J. D., Hu, W.-S., & Pathak, V. K. (2006) · Virology · doi:10.1016/j.virol.2006.10.036 · Cited by 114
Self-citationSvarovskaia, E. S., Barr, R., Zhang, X., Pais, G. C. G., Marchand, C., Pommier, Y. G., Burke, T. R., & Pathak, V. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3210-3222.2004 · Cited by 113
Self-citationWang, Z., & Mosbaugh, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85067-6 · Cited by 106
Thomas, J. A., Gagliardi, T. D., Alvord, W. G., Lubomirski, M. S., Bosche, W. J., & Gorelick, R. J. (2006) · Virology · doi:10.1016/j.virol.2006.05.014 · Cited by 98
Self-citationPriet, S., Gros, N., Navarro, J., Boretto, J., Canard, B., Quérat, G., & Sire, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.016 · Cited by 96
Nikolenko, G. N., Svarovskaia, E. S., Delviks‐Frankenberry, K. A., & Pathak, V. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8761-8770.2004 · Cited by 93
Self-citationOmer, C. A., & Faras, A. J. (1982) · Cell · doi:10.1016/0092-8674(82)90284-7 · Cited by 87
Smith, J. S., & Roth, M. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42147-3 · Cited by 84
Klarmann, G. J., Chen, X., North, T. W., & Preston, B. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207223200 · Cited by 84
Willetts, K. E., Gondois‐Rey, F., Agostini, I., Navarro, J., Baudat, Y., Vigne, R., & Sire, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1682-1688.1999 · Cited by 82
A New Type of G→A Hypermutation Affecting Human Immunodeficiency Virus
Fitzgibbon, J. E., Mazar, S., & Dubin, D. T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.833 · Cited by 79
Inhibitors of Human Immunodeficiency Virus Integrase
Pommier, Y. G., & Neamati, N. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60310-3 · Cited by 78
Harris, R. S., Sheehy, A. M., Craig, H. M., Malim, M. H., & Neuberger, M. S. (2003) · Nature Immunology · doi:10.1038/ni0703-641 · Cited by 76
Self-citationKao, S., Akari, H., Khan, M. A., Dettenhofer, M., Yu, X.-F., & Strebel, K. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1131-1140.2003 · Cited by 62
Huthoff, H., & Malim, M. H. (2005) · Virology · doi:10.1016/j.virol.2005.01.038 · Cited by 61
Lu, R., Vandegraaff, N., Cherepanov, P., & Engelman, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12584-12591.2005 · Cited by 41
Self-citationVoronin, Y. A., & Pathak, V. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5402-5413.2004 · Cited by 11
Self-citation
Cited by
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 532
Hu, W.-S., & Hughes, S. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006882 · Cited by 505
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
HIV-1 Vif, APOBEC, and Intrinsic Immunity
Goila-Gaur, R., & Strebel, K. (2008) · Retrovirology · doi:10.1186/1742-4690-5-51 · Cited by 342
Metadata
- Authors
- Mbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., Engelman, A., & Pathak, V. K.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-07
- Volume
- 81
- Issue
- 13
- Pages
- 7099-7110
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2104808073
- Cited by
- 274
- References
- 54
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.